Timothy J Bell

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. doi request reprint The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)
    Timothy J Bell
    GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA
    Pain Med 10:35-42. 2009
  2. doi request reprint Economic analysis of alvimopan in North American Phase III efficacy trials
    Timothy J Bell
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Am J Health Syst Pharm 66:1362-8. 2009

Detail Information

Publications2

  1. doi request reprint The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)
    Timothy J Bell
    GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA
    Pain Med 10:35-42. 2009
    ..This multinational, Internet-based survey was designed to assess the prevalence, frequency, severity, and impact of opioid-induced bowel dysfunction (OBD) in patients receiving opioid therapy for chronic pain and taking laxatives...
  2. doi request reprint Economic analysis of alvimopan in North American Phase III efficacy trials
    Timothy J Bell
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Am J Health Syst Pharm 66:1362-8. 2009
    ..The economic effect of the use of alvimopan in four randomized, double-blind, placebo-controlled, Phase III, North American efficacy trials was analyzed...